Skip to main content
Erschienen in: Heart and Vessels 6/2011

01.11.2011 | Original Article

In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction

verfasst von: Pavel Poredos, Mateja Kaja Jezovnik

Erschienen in: Heart and Vessels | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the levels of anti-inflammatory interleukin-10 and pro-inflammatory cytokines and their relationship to endothelial function in patients with idiopathic venous thrombosis. Forty-nine eligible patients of both sexes with idiopathic venous thrombosis and 48 matched control subjects were studied. Levels of inflammatory markers were determined. Endothelial function was evaluated by ultrasound measurement of the flow mediated dilatation (FMD) of the brachial artery. Compared to the control group, patients with idiopathic venous thrombosis had significantly lower levels of interleukin-10 1.81 pg/ml (1.53–2.21) versus 2.71 pg/ml (1.84–3.65), p < 0.001. Patients also had increased levels of pro-inflammatory cytokines: interleukin-6 2.37 pg/ml (1.59–4.09) versus 2.03 pg/ml (1.49–2.59), p = 0.025, interleukin-8 3.53 pg/ml (2.94–5.30) versus 2.25 pg/ml (1.77–2.90), p < 0.001. Furthermore, decreased FMD was observed in patients: 5.0% (3.9–6.9) versus 12.7% (10.8–15.6), p < 0.001. FMD was related to levels of interleukin-10 (r = 0.33, p = 0.001) and was inversely related to pro-inflammatory cytokines interleukin-6 (r = −0.34, p = 0.001) and interleukin-8 (r = −0.43, p < 0.001). Patients with idiopathic venous thrombosis have decreased levels of IL-10 and increased levels of pro-inflammatory cytokines. This imbalance indicates that in the stable phase of the disease, patients have an increased systemic inflammatory response. This inflammatory response could be the consequence of the disease, but most probably is involved in the pathogenesis of venous thrombosis.
Literatur
1.
Zurück zum Zitat Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979PubMedCrossRef Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979PubMedCrossRef
2.
Zurück zum Zitat Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107:I9–I16PubMedCrossRef Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107:I9–I16PubMedCrossRef
3.
Zurück zum Zitat Conde I, Lopez JA (2005) Classification of venous thromboembolism (VTE). Role of acute inflammatory stress in venous thromboembolism. J Thromb Haemost 3:2573–2575PubMedCrossRef Conde I, Lopez JA (2005) Classification of venous thromboembolism (VTE). Role of acute inflammatory stress in venous thromboembolism. J Thromb Haemost 3:2573–2575PubMedCrossRef
4.
Zurück zum Zitat Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ (1997) Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg 5:6–15PubMedCrossRef Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ (1997) Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg 5:6–15PubMedCrossRef
5.
Zurück zum Zitat Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539–552PubMedCrossRef Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539–552PubMedCrossRef
6.
Zurück zum Zitat Reitsma PH, Rosendaal FR (2004) Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2:619–622PubMedCrossRef Reitsma PH, Rosendaal FR (2004) Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2:619–622PubMedCrossRef
7.
Zurück zum Zitat Downing LJ, Strieter RM, Kadell AM, Wilke CA, Austin JC, Hare BD, Burdick MD, Greenfield LJ, Wakefield TW (1998) IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 161:1471–1476PubMed Downing LJ, Strieter RM, Kadell AM, Wilke CA, Austin JC, Hare BD, Burdick MD, Greenfield LJ, Wakefield TW (1998) IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 161:1471–1476PubMed
8.
Zurück zum Zitat Pradier O, Gerard C, Delvaux A, Lybin M, Abramowicz D, Capel P, Velu T, Goldman M (1993) Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23:2700–2703PubMedCrossRef Pradier O, Gerard C, Delvaux A, Lybin M, Abramowicz D, Capel P, Velu T, Goldman M (1993) Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23:2700–2703PubMedCrossRef
9.
Zurück zum Zitat Del Prete G, De Carli M, Lammel RM, D’Elios MM, Daniel KC, Giusti B, Abbate R, Romagnani S (1995) Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 86:250–257PubMed Del Prete G, De Carli M, Lammel RM, D’Elios MM, Daniel KC, Giusti B, Abbate R, Romagnani S (1995) Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 86:250–257PubMed
10.
Zurück zum Zitat Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102:1000–1006PubMed Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102:1000–1006PubMed
11.
Zurück zum Zitat Bhagat K, Vallance P (1997) Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96:3042–3047PubMed Bhagat K, Vallance P (1997) Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96:3042–3047PubMed
12.
Zurück zum Zitat Migliacci R, Becattini C, Pesavento R, Davi G, Vedovati MC, Guglielmini G, Falcinelli E, Ciabattoni G, Dalla Valle F, Prandoni P, Agnelli G, Gresele P (2007) Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 92:812–818PubMedCrossRef Migliacci R, Becattini C, Pesavento R, Davi G, Vedovati MC, Guglielmini G, Falcinelli E, Ciabattoni G, Dalla Valle F, Prandoni P, Agnelli G, Gresele P (2007) Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 92:812–818PubMedCrossRef
13.
Zurück zum Zitat Jezovnik MK, Poredos P, Stalc M (2010) Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venous thrombosis. J Atheroscler Thromb 17:1190–1198PubMedCrossRef Jezovnik MK, Poredos P, Stalc M (2010) Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venous thrombosis. J Atheroscler Thromb 17:1190–1198PubMedCrossRef
14.
Zurück zum Zitat Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher AM (2004) Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol 44:44–49PubMedCrossRef Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher AM (2004) Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol 44:44–49PubMedCrossRef
15.
Zurück zum Zitat Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef
16.
17.
Zurück zum Zitat Christiansen SC, Naess IA, Cannegieter SC, Hammerstrom J, Rosendaal FR, Reitsma PH (2006) Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med 3:e334PubMedCrossRef Christiansen SC, Naess IA, Cannegieter SC, Hammerstrom J, Rosendaal FR, Reitsma PH (2006) Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med 3:e334PubMedCrossRef
18.
Zurück zum Zitat Dosquet C, Weill D, Wautier JL (1995) Cytokines and thrombosis. J Cardiovasc Pharmacol 25(Suppl 2):S13–S19PubMedCrossRef Dosquet C, Weill D, Wautier JL (1995) Cytokines and thrombosis. J Cardiovasc Pharmacol 25(Suppl 2):S13–S19PubMedCrossRef
19.
Zurück zum Zitat Chrysohoou C, Pitsavos C, Barbetseas J, Kotroyiannis I, Brili S, Vasiliadou K, Papadimitriou L, Stefanadis C (2009) Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study). Heart Vessels 24:22–26PubMedCrossRef Chrysohoou C, Pitsavos C, Barbetseas J, Kotroyiannis I, Brili S, Vasiliadou K, Papadimitriou L, Stefanadis C (2009) Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study). Heart Vessels 24:22–26PubMedCrossRef
20.
Zurück zum Zitat Derosa G, Ferrari I, D’Angelo A, Salvadeo SA, Fogari E, Gravina A, Mereu R, Palumbo I, Maffioli P, Randazzo S, Cicero AF (2009) Oral fat load effects on inflammation and endothelial stress markers in healthy subjects. Heart Vessels 24:204–210PubMedCrossRef Derosa G, Ferrari I, D’Angelo A, Salvadeo SA, Fogari E, Gravina A, Mereu R, Palumbo I, Maffioli P, Randazzo S, Cicero AF (2009) Oral fat load effects on inflammation and endothelial stress markers in healthy subjects. Heart Vessels 24:204–210PubMedCrossRef
21.
Zurück zum Zitat Bergman M, Djaldetti M, Salman H, Bessler H (2010) On the combined effect of statins and lycopene on cytokine production by human peripheral blood cells. Heart Vessels 25:426–431PubMedCrossRef Bergman M, Djaldetti M, Salman H, Bessler H (2010) On the combined effect of statins and lycopene on cytokine production by human peripheral blood cells. Heart Vessels 25:426–431PubMedCrossRef
22.
Zurück zum Zitat Roumen-Klappe EM, den Heijer M, van Uum SH, van der Ven-Jongekrijg J, van der Graaf F, Wollersheim H (2002) Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg 35:701–706PubMedCrossRef Roumen-Klappe EM, den Heijer M, van Uum SH, van der Ven-Jongekrijg J, van der Graaf F, Wollersheim H (2002) Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg 35:701–706PubMedCrossRef
23.
Zurück zum Zitat Proctor MC, Sullivan V, Zajkowski P, Wolk SW, Pomerantz RA, Wakefield TW, Greenfield LJ (2006) A role for interleukin-10 in the assessment of venous thromboembolism risk in injured patients. J Trauma 60:147–151PubMedCrossRef Proctor MC, Sullivan V, Zajkowski P, Wolk SW, Pomerantz RA, Wakefield TW, Greenfield LJ (2006) A role for interleukin-10 in the assessment of venous thromboembolism risk in injured patients. J Trauma 60:147–151PubMedCrossRef
24.
Zurück zum Zitat Poredos P (2004) Involvement of endothelial dysfunction in atherogenesis. In: Clark JV (ed) Focus on atherosclerosis research. Nova Science Publishers, Inc, Hauppauge, NY, USA, pp 165–183 Poredos P (2004) Involvement of endothelial dysfunction in atherogenesis. In: Clark JV (ed) Focus on atherosclerosis research. Nova Science Publishers, Inc, Hauppauge, NY, USA, pp 165–183
25.
Zurück zum Zitat Taddei S, Salvetti A (2002) Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 20:1671–1674PubMedCrossRef Taddei S, Salvetti A (2002) Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 20:1671–1674PubMedCrossRef
26.
Zurück zum Zitat Poredos P, Kek A (2000) Relation of blunted dilation of the brachial artery in insulin-dependent diabetes mellitus to microalbuminuria. Am J Cardiol 86:364–367PubMedCrossRef Poredos P, Kek A (2000) Relation of blunted dilation of the brachial artery in insulin-dependent diabetes mellitus to microalbuminuria. Am J Cardiol 86:364–367PubMedCrossRef
27.
Zurück zum Zitat Commins S, Steinke JW, Borish L (2008) The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121:1108–1111PubMedCrossRef Commins S, Steinke JW, Borish L (2008) The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121:1108–1111PubMedCrossRef
Metadaten
Titel
In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction
verfasst von
Pavel Poredos
Mateja Kaja Jezovnik
Publikationsdatum
01.11.2011
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 6/2011
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-010-0111-3

Weitere Artikel der Ausgabe 6/2011

Heart and Vessels 6/2011 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.